SEC Form 4 · accession 0001628280-15-001049
LA JOLLA PHARMACEUTICAL CO · LJPC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Craig A Johnson
Director
Period of report
Feb 23, 2015
Accepted (ET)
Feb 25, 2015 · 8:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000920465
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $19.69 | Feb 23, 2015 | A | 10,000 | A | — | Feb 23, 2025 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1This option represents a right to purchase a total of 10,000 shares of the Issuer's Common Stock, which shall be fully vested and exercisable on February 23, 2016.